A complex protein module keeps the liver’s biochemical factory running smoothly and at capacity.

Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.

Marc Pelletier traveled from Cambridge, MA to Shanghai, China, to launch new lines of research for the treatment of cancers that are common in China.

For all too many people living with heart failure, hospitalizations are a recurring part of life, affecting the lives of both patients and their caregivers.

Talk to any cancer researcher or doctor today and what you hear is wonder and hope.

Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.

Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

A researcher in South Africa investigating a rare skin disease was losing hope of a breakthrough. Then she made a discovery.

Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.